RELAPSE/RECURRENCE
Clinical trials for RELAPSE/RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE/RECURRENCE trials appear
Sign up with your email to follow new studies for RELAPSE/RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New trial tests gentler chemo for Tough-to-Treat leukemia
Disease control Recruiting nowThis study compares two treatment approaches for adults whose acute myeloid leukemia has returned or not responded to initial therapy. Participants will receive either a milder, low-intensity therapy or a stronger, high-dose chemotherapy. The goal is to see if the gentler option …
Matched conditions: RELAPSE/RECURRENCE
Phase: PHASE3 • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated May 26, 2026 11:06 UTC
-
New antibody combo shows promise for hard-to-treat lymphoma
Disease control Recruiting nowThis study tests whether adding the experimental drug lacutamab to standard chemotherapy helps people with a rare type of blood cancer (peripheral T-cell lymphoma) that has returned or stopped responding to treatment. About 56 adults whose cancer cells have a specific marker call…
Matched conditions: RELAPSE/RECURRENCE
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated May 22, 2026 13:50 UTC